PuSH - Publikationsserver des Helmholtz Zentrums München

81 Datensätze gefunden.
Zum Exportieren der Ergebnisse bitte einloggen.
Alle Publikationen dieser Seite in den Korb legen
1.
Combs, S.E. et al.: ESTRO ACROP guideline for target volume delineation of skull base tumors. Radiother. Oncol. 156, 80-94 (2021)
2.
Nguyen, L. et al.: Impact of DNA repair and reactive oxygen species levels on radioresistance in pancreatic cancer. Radiother. Oncol. 159, 265-276 (2021)
3.
Peeken, J.C. et al.: MRI-based delta-radiomics predicts pathologic complete response in high-grade soft-tissue sarcoma patients treated with neoadjuvant therapy. Radiother. Oncol. 164, 73-82 (2021)
4.
Borm, K.J.* et al.: Irradiation of regional lymph node areas in breast cancer - Dose evaluation according to the Z0011, AMAROS, EORTC 10981-22023 and MA-20 field design. Radiother. Oncol. 142, 195-201 (2020)
5.
Akhgar, J.* ; Peeken, J.C. ; Pigorsch, S.U.* & Combs, S.E.: Response prediction of palliative radiotherapy to painful spinal bone metastases. Radiother. Oncol. 133, S879-S880 (2019)
6.
Bartzsch, S.: Compact microbeam sources and microbeam treatment planning. Radiother. Oncol. 133, S176-S177 (2019)
7.
Bierbaumer, D.* et al.: Impact of diabetes on outcome and toxicity of neoadjuvant (chemo)radiation for rectal cancer. Radiother. Oncol. 133, S794-S795 (2019)
8.
Bierbaumer, D.* et al.: Impact of diabetes on outcome and toxicity of chemoradiation for esophageal squamous cell carcinoma. Radiother. Oncol. 133, S780-S780 (2019)
9.
Brunner, T.B.* et al.: Stereotactic body radiotherapy dose and its impact on local control and overall survival of patients for locally advanced intrahepatic and extrahepatic cholangiocarcinoma. Radiother. Oncol. 132, 42-47 (2019)
10.
Dapper, H.* et al.: A PET-based patterns of failure analysis in the context of contouring guidelines in anal cancer. Radiother. Oncol. 133, S193-S194 (2019)
11.
Diehl, C.D.* et al.: Application of presurgical navigated transcranial magnetic stimulation motor mapping for adjuvant radiotherapy planning in patients with high-grade gliomas. Radiother. Oncol. 138, 30-37 (2019)
12.
Gerhardt, A.S.* et al.: Influence of rotational setup errors on dose in target and organs at risk in cranial radiotherapy. Radiother. Oncol. 133, S1210-S1211 (2019)
13.
Hirmer, E. et al.: The interaction between miR-221 overexpression and radiosensitivity in mamma carcinoma cell lines. Radiother. Oncol. 133, S603-S604 (2019)
14.
Hombrink, G. ; Wilkens, J.J.* ; Combs, S.E. & Bartzsch, S.: Microcavities in the lung affect the dose distribution in microbeam radiation therapy. Radiother. Oncol. 133, S47-S48 (2019)
15.
Kessel, K.A. et al.: Influence of PET-imaging during treatment planning on outcome in meningioma patients. Radiother. Oncol. 133, S690-S691 (2019)
16.
Klapproth, A.* et al.: MC simulations on the dose enhancement effect of antibody conjugated AuNPs in targeted radiotherapy. Radiother. Oncol. 133, S1147-S1148 (2019)
17.
Kundrat, P. et al.: Minimum breast distance largely explains individual variability in doses to contralateral breast from breast-cancer radiotherapy. Radiother. Oncol. 131, 186-191 (2019)
18.
Linge, A.* et al.: TCGA molecular subclassification is prognostic for LRC of HNSCC after postoperative RCTx. Radiother. Oncol. 133, S196-S196 (2019)
19.
Oechsner, M.* et al.: Gated treatment of left-sided breast cancer: Evaluation of lung movement, irradiated volume and mass. Radiother. Oncol. 133, S715-S715 (2019)
20.
Peeken, J.C. et al.: CT-based radiomic features predict tumor grading and have prognostic value in patients with soft tissue sarcomas treated with neoadjuvant radiation therapy. Radiother. Oncol. 135, 187-196 (2019)